During the past decade, Universitätsklinikum Düsseldorf, Frauenklinik conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Düsseldorf, Frauenklinik" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "University Hospital Tuebingen" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "Alliance Foundation Trials, LLC." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Düsseldorf, Frauenklinik" #1 collaborator was "German Breast Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Düsseldorf, Frauenklinik" are "Breast Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Advanced/Metastatic Breast Cancer" (1 trials) and "Breast Cancer (Early Breast Cancer)" (1 trials). Many other conditions were trialed in "Universitätsklinikum Düsseldorf, Frauenklinik" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Düsseldorf, Frauenklinik" are "Drug" (10 trials), "Biological" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Bevacizumab" (2 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Düsseldorf, Frauenklinik" are 6 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Universitätsklinikum Düsseldorf, Frauenklinik". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Universitätsklinikum Düsseldorf, Frauenklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Düsseldorf, Frauenklinik, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".